A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2)

PURPOSE: Development of new treatment strategies for endometrial cancer that has become refractory or resistant to taxane/platinum is a critical need. The present study was a phase I/II study of gemcitabine, levofolinate, irinotecan, and 5-fluorouracil (5-FU) (GLIF) combination chemotherapy to deter...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Yusuke, Ueda, Yutaka, Nakagawa, Satoshi, Matsuzaki, Shinya, Kobayashi, Eiji, Shiki, Yasuhiko, Nishio, Yukihiro, Takemura, Masahiko, Yamamoto, Toshiya, Sawada, Kenjiro, Tomimatsu, Takuji, Yoshino, Kiyoshi, Kimura, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132850/
https://www.ncbi.nlm.nih.gov/pubmed/30030584
http://dx.doi.org/10.1007/s00280-018-3648-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132850/
https://www.ncbi.nlm.nih.gov/pubmed/30030584
http://dx.doi.org/10.1007/s00280-018-3648-y

Ejemplares similares